Results 151 to 160 of about 234,721 (311)
Extracellular vesicles (EVs) play a dual role in diagnostics and therapeutics, offering innovative solutions for treating cancer, cardiovascular, neurodegenerative, and orthopedic diseases. This review highlights EVs’ potential to revolutionize personalized medicine through specific applications in disease detection and treatment.
Farbod Ebrahimi+4 more
wiley +1 more source
Optimization of ski jumping in-run posture using computational fluid dynamics. [PDF]
Liu W, Lu F, Suo X, Tang W.
europepmc +1 more source
Symposium on GARP and dedication of the Geophysical Fluid Dynamics Laboratory at Princeton University [PDF]
openalex +1 more source
Using supramolecular monomers, various hydrogel culture systems were formulated to culture protoplasts; including 2D, 2.5D, and 3D hydrogels. Depending on the culture platform, bioactive functionalization led to protoplast enlargement (2D and 2.5D) or plasmolysis (3D). This work shows the potential to modularly engineer synthetic platforms for cellular
Maritza M. Rovers+3 more
wiley +1 more source
Improving fluid dynamics during root canal irrigation. [PDF]
Asthana G, Manglani S, Tamuli R.
europepmc +1 more source
The particle-in-cell method for numerical solution of problems in fluid dynamics
Francis H. Harlow
openalex +2 more sources
LIN28B Promotes Cancer Cell Dissemination and Angiogenesis
Children diagnosed with high‐risk neuroblastoma have a 5‐year event‐free survival rate of less than 50% and poor outcomes after recurrence. Deregulation of the LIN28B oncogene can be addressed in these patients. Upregulation of LIN28B is shown to support the metastatic cascade.
Diana Corallo+8 more
wiley +1 more source
Bayesian inference for geophysical fluid dynamics using generative models. [PDF]
Lobbe A, Crisan D, Lang O.
europepmc +1 more source
PARTICLE-IN-CELL METHOD FOR THE CALCULATION OF THE DYNAMICS OF COMPRESSIBLE FLUIDS
A.A. Amsden
openalex +2 more sources
The prodrug strategy used in this study offers new promise for cancer metabolism‐based therapies. JHU083, a prodrug that, when cleaved by protease in the tumor microenvironment, yields the glutamine antagonist DON. JHU083 inhibits tumor growth by targeting glutamine‐addicted cancer cells and suppressing glutamine‐dependent M2 macrophages, leading to a ...
Tianhe Li+10 more
wiley +1 more source